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Brief Communication
A Gut Feeling: A Hypothesis of the Role
of the Microbiome in Attention-Deficit/
Hyperactivity Disorders
Xue Ming, MD, PhD1, Neil Chen, BS1, Carly Ray, BS1, Gretchen Brewer, BS1,
Jeffrey Kornitzer, MD1, and Robert A. Steer, EdD2
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a neurologic disorder characterized by hyperactivity/impulsivity and/or
inattentiveness, with genetic and environmental factors contributing to the disorder. With the growing recognition of the
microbiome’s role in many neurological disorders, the authors propose that it may also be implicated in ADHD. Here, we
describe several evolving areas of research to support this hypothesis. First, a unique composition of gut bacteria has been
identified and linked to behaviors in ADHD. Second, our research found an increased incidence of 2 gastrointestinal symptoms
(constipation and flatulence) in children with ADHD, as compared to controls. Finally, emerging data may be interpreted to
suggest that immune dysregulation in ADHD be associated with an altered microbiome, low-grade inflammation, and gastro-
intestinal dysfunction. Although more studies are needed to elucidate exact mechanisms and causality, we propose that an altered
microbiome, gastrointestinal symptoms, and immune dysregulation may be associated with the ADHD phenotypes.
Keywords
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Attention-deficit/hyperactivity disorder (ADHD) is a neurode-
velopmental and neurobehavioral disorder characterized by
hyperactivity/impulsivity (ADHD, predominantly hyperac-
tive/impulse type), inattentiveness (ADHD, predominantly
inattentive type), or both (ADHD, combined type).1 Despite
being one of the most prevalent neurodevelopmental condi-
tions, affecting approximately 6% of United States children
aged 4 to 17 years old, the etiology of the disorder remains
unclear.2,3 It is widely accepted that ADHD is heritable,
although only a small number of genes have been reported to
have a relatively small effect in predicting ADHD.4–6 At the
same time, studies have shown that children with a parent
diagnosed with ADHD have a greater than 50% chance of
having ADHD; twin studies have suggested a heritability of
71% to 90% for the various subtypes of ADHD.7 Concurrently,
it is estimated that between 10% and 40% of the variance in
heritance may be due to environmental factors.3 For example,
perinatal stress, maternal smoking, and alcohol use during
pregnancy, lead exposure, and micronutrient and mineral
deficiencies have all been noted as increasing the risk of
developing ADHD.8 Nonetheless, these known environmental
factors do not account for all of the variance in heritability.
In recent years, the gut microbiome has been associated with
many psychiatric and neurodevelopmental disorders, including
autism spectrum disorders, depression, anorexia nervosa, and
Rett syndrome.9–13 Consisting of several trillion commensal
microbes, the microbiome plays an active role in maintaining
health throughout life. In a system known as the gut–brain axis,
the gut microbiome continuously “converses” with the central
nervous system through hormonal, immune, and innate neuro-
nal pathways.14 These pathways, established through
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microbiota metabolites, may be critical to the development of
the central nervous system, including the brain.15 Murine mod-
els mimicking an environment devoid of a gut microbiome,
such as the murine germ-free models, demonstrate abnormal
neurotransmitter profiles and abnormal neuroanatomy. In one
study of murine germ-free models, postsynaptic density protein
95 and synaptophysin were found to be increased, suggesting
increased excitatory synapse and synaptic vesicle maturation in
regions of the brain associated with motor control and anxiety-
like behaviors.15,16 In another study, germ-free mice developed
hypermyelinated axons which normalized following subse-
quent colonization with conventional microbiota. Furthermore,
defects in microglia cells were also partially restored following
colonization with conventional microbiota.17,18 Similarly, in
humans, it is hypothesized that dysbiosis (eg, imbalance of the
microbiota) may have a negative effect on the most critical
moments of cerebral development, leading to lasting or perma-
nent modifications to the CNS and its function.19
Studies have shown that, in addition to roles in digestion and
detoxification, gut flora is critically involved in immunoregu-
lation. In dysbiosis, there may be a disproportionate quantity of
pro-inflammatory microbes, leading to increased intestinal per-
meability and inflammation as well as a resultant shift of
microbes into the systemic circulation, which may lead to
low-grade systemic inflammation and immune dysregulation.20
Literature has generally supported the relationship linking
autoimmune disorders with dysbiosis.21–23
Immune dysfunction has been speculated to be associated
with ADHD. In general, it has been proposed that low-grade
systemic inflammation may lead to gradual destruction of the
blood–brain barrier and possibly the neuroinflammation seen
in ADHD.24,25 Supporting this theory, a review profiling cyto-
kine levels in cerebral spinal fluid and serum along with
related gene polymorphisms found evidence to suggest that
there is low-level inflammation present in children with
ADHD. The authors acknowledge a high level of variability
in the findings, though it is possible that this may result from
the heterogeneity of ADHD itself.26 Other studies have found
that environmental stresses in pregnancy, such as poor mater-
nal diet, infection, antibiotic use, or stress, lead to an
increased incidence of offspring with behavior problems,
including ADHD; again, inflammation due to these stresses
may be implicated in the pathogenesis of ADHD.27–31 Finally,
the increased incidence of immune-mediated disorders such
as asthma and atopic dermatitis among patients with ADHD
likewise suggests immune dysfunction in children with
ADHD.32 Although these links are tenuous and speculative,
they may be deserving of further investigation.
Hypothesis
We hypothesize that perturbations in the host gut microbiome,
increased gastrointestinal symptoms, immune dysregulation,
and alterations in metabolomic markers may be present in some
children with ADHD.
Evaluation of the Hypothesis
Altered Microbiome in ADHD
Although gut microbiome studies in ADHD are in their early
days, there is emerging interests in differences between the
microbiome in patients with ADHD as compared to that of
neurotypical controls. Using 16S rRNA marker gene sequen-
cing, Aarts et al noted a slight increase in Bifidobacterium
genus in patients with ADHD. With the bacterial gene func-
tionality encoding cyclohexadienyl dehydratase, an enzyme
utilized in the synthesis of phenylalanine (itself a dopamine
precursor), the authors sought to indirectly correlate Bifidobac-
terium prevalence with its effect on neural reward anticipation
(a known functional target of dopamine), as suggested in ven-
tral striatal fMRI responses to reward anticipation. Indeed, the
authors noted a diminished neural reward anticipation as being
correlated with increased Bifidobacterium in the gut.33 Given
the known association between ADHD and dopamine dysregu-
lation,34 as well as abnormally decreased reward anticipation
pathways,35 this study speculated that dysbiosis may contribute
to the clinical phenotypes of ADHD.
Prevalence of Gastrointestinal Symptoms in ADHD
An altered gut microbiome can be associated with gastrointest-
inal symptoms, such as constipation, diarrhea, abdominal pain,
and flatulence. A number of studies have also documented an
increased incidence of gastrointestinal symptoms in neurode-
velopmental disorders.36–39 Establishing whether children with
ADHD have more symptoms of gastrointestinal dysfunction
than their neurotypical counterparts may be a first step toward
determining whether there are clinical manifestations of dys-
biosis in ADHD.
We administered the 6-item Gastrointestinal Severity
Index (see Table 1) to 68 children with ADHD (aged 3-16
years old) and 72 healthy controls (aged 3-16 years old). Mean
age of the cohort was 9.96 + 3.24 years (see Table 2).
Patients were recruited from general pediatric clinics (for
neurotypical controls) and from pediatric neurology clinics
(for patients with ADHD) at University Hospital in Newark,
New Jersey. A diagnosis of ADHD was based upon the clin-
ical criteria in the DSM-IV-TR and/or DSM-V criteria with
consideration of developmental level. Children with comor-
bid disorders, such as an autism spectrum disorder, Tourette
syndrome, learning disability, or speech delay, were excluded
from the study. Thirty-three of the 68 children were on a
sympathomimetic stimulant. Twelve patients were on an a-
adrenergic agonist such as clonidine. Among the medication
users, 3 were on both categories of medications. Gastrointest-
inal Severity Index was validated in children with autism
spectrum disorders in our prior study40; to our knowledge, its
use in ADHD has not been validated.
Control participants were recruited during their wellness
visits and were screened for medical and developmental dis-
orders prior to enrollment. Specifically, any children with
symptoms of ADHD were excluded. Informed consent was
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obtained from parents/guardians according to the protocol
approved by the institutional review board of our institute. The
Gastrointestinal Severity Index was administered to the
patients at the time of visit for ages 5 years old and above; for
patients below 5 years old, the parents were asked to complete
the survey. The Gastrointestinal Severity Index allows for rat-
ing the severity of gastrointestinal symptoms using a 3-point
Likert rating scale ranging from 0 (“none/normal”) to 2
(“severe/significant”) for 6 gastrointestinal symptoms (consti-
pation, diarrhea, average stool consistency, stool smell, flatu-
lence, and abdominal pain) (Table 1). Children with ADHD
had significantly higher mean Gastrointestinal Severity Index
total, constipation, and flatulence scores than the healthy con-
trols (Table 3). These gastrointestinal symptoms were not
severe in the majority of children with ADHD in this cohort.
Aside from a small correlation of total Gastrointestinal Severity
Index scores with sex (0 ¼ male, 1 ¼ female) in the ADHD
group (r ¼ 0.271; P ¼ .026), there were no significant correla-
tions for the total Gastrointestinal Severity Index score with
sex, age, and BMI in either group.
Despite previous reports that use of stimulant medica-
tions, such as methylphenidate, may contribute to abdominal
pain,41 we did not find any significant relationship between
medication use and constipation, flatulence, or total Gastro-
intestinal Severity Index score (ie, stimulant, nonstimulants,
both stimulant and nonstimulant, or no stimulant/nonstimu-
lant use groups).
Discussion
Our findings contribute to a small but growing body of litera-
ture describing gastrointestinal disturbance in patients with
ADHD. One large study of parental reports (n ¼ 6483) of
comorbidities in ADHD found significantly increased rates of
“serious stomach or bowel problems” (defined as problems
such as gastritis or ulcers) in ADHD, even after adjusting for
demographics and other medical/mental disorders of a nation-
ally representative sample. Interestingly, gastrointestinal dis-
turbances and enuresis were the only 2 comorbidities found
to be significantly more likely in this large cohort of ADHD.42
In parsing out specific gastrointestinal symptoms, Duel et al43
found increased rates of constipation in a group of 28 children
with ADHD. In a large, retrospective study using a military
database, children with ADHD (n ¼ 32 773) were more likely
to have fecal incontinence and constipation than those without
ADHD.44 In terms of abdominal pain, one study found a 2-fold
increased risk of recurrent abdominal pain among children with
ADHD.45 A comparison of these studies with ours is illustrated
in Table 4. Gastrointestinal symptoms could be associated with
anxiety, mood disorders, dietary intake, and many other fac-
tors; these confounders were not considered in the studies.
However, Almog et al46 found no significant correlation
between gastrointestinal symptoms and ADHD in a cohort of
62 Israeli children.
Table 1. The 6-Item GSI Score.
Category
Score
0 1 2
Constipation 5 stools per week 3-4 stools per week 0-2 stools per week
Diarrhea 0-1 loose stools per day 2-3 loose stools per day 4 loose stools per day
Average stool consistency Formed Loose/unformed 3 days per week Watery 3 days per week
Stool smell Normal Abnormal 3 days per week Unusually foul 3 days per week
Flatulence Normal Frequent  3 days per week Daily
Abdominal pain None Mild discomfort 3 times per week Moderate to severe discomfort 3 times per week
Abbreviation: GSI, Gastrointestinal Severity Index.
Table 2. Demographic Features of the Participants.
Variable ADHD Control
Male (% of group) 51 (75%) 33 (46%)
Female (% of group) 17 (25%) 39 (54%)
Mean age (SD) 10.3 years (+ 2.97) 9.7 years (3.24)
Mean BMI (SD) 20.3 kg/m2 (+ 4.99) 20.4 kg/m2 (5.27)
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; BMI, body mass
index; SD, standard deviation.
Table 3. Mean GSI Total and Symptom Scores for ADHD and
Control Groupsa,b.
Variable
ADHD
(N¼68)
Control
(N¼72)
t df PM SD M SD
GSI total score 1.13 1.48 .38 1.04 3.248 119 <.001
Constipation 0.34 0.66 0.13 0.41 2.28 110 .024
Diarrhea 0.01 0.12 0 0 1.00 67 .321
Consistency 0.01 0.12 0.01 0.12 0.04 138 .968
Smell 0.13 0.42 0.08 0.32 0.77 138 .443
Flatulence 0.28 0.62 0.08 0.32 2.33 126 .019
Abdominal pain 0.34 0.64 0.07 31 3.15 95 .269
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; df, degrees of
freedom; GSI, Gastrointestinal Severity Index; M, mean; SD, standard deviation.
aTotal N ¼ 140.
bIf dfs ¼ 138, then an independent t test for equal variances was used to
compare the mean scores. If the dfs are <138, Welch t statistic for unequal
variance was employed to compare the mean scores.
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Conclusion
Increased gastrointestinal symptoms among patients with
ADHD may be suggestive of an altered microbiome. Practical
approaches to testing the hypothesis would include controlled
studies to further characterize the microbiome in ADHD, as has
been done in autism spectrum disorders. Investigating any cor-
relation between clinical gastrointestinal symptoms and gut
dysbiosis may address the increased prevalence of gastrointest-
inal symptoms in children with ADHD. Further basic science
and clinical studies are then needed to understand the neuro-
transmitter, neurometabolic, neuroanatomic changes, if any,
that dysbiosis may cause. Furthermore, any potential gut dys-
biosis would need to be correlated with immunological pro-
files. If there is gut dysbiosis causing neurotransmitter,
neurometabolic, neuroanatomic, and/or immunologic abnorm-
alities in children with ADHD, our treatment paradigm of
ADHD could expand to treat gut dysbiosis and immunologic
disturbances, and not just the presenting neurological symp-
toms. Of course, the contribution of gastrointestinal dysbiosis
to ADHD symptomatology, if any, would need to be viewed
within a greater framework that addresses broader genetic and
environmental etiologic factors.
We propose that gut dysbiosis should be explored for a
potential role in contributing symptoms of ADHD, supported
by our finding of a modest increased prevalence of gastroin-
testinal dysfunction (namely, constipation and flatulence) in
children with ADHD. These differences are consistent with
recent literature suggesting an association between ADHD and
gastrointestinal disturbance as well as gut dysbiosis (such as a
slight increase in Bifidobacterium genus in patients with
ADHD). Furthermore, a role of immune dysfunction in ADHD
should be further investigated and an association with gut dys-
biosis, if present, should likewise be explored. These findings
may, in turn, shed light on a previously uncharted piece of the
ADHD puzzle.
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